Loading the section…
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Revenue | 4M | 27M | 15M | 4M |
| Research and development | 56M | 63M | 55M | 60M |
| Selling, general and administrative | 16M | 17M | 15M | 16M |
| Operating income | −69M | −52M | −54M | −71M |
| Pre-tax income | −70M | −51M | −54M | −71M |
| Income tax | 0 | 3,000 | 10,000 | 13,000 |
| Net income | −70M | −51M | −54M | −71M |
| Earnings per share | −0.70 | −0.51 | −0.64 | −0.85 |
| Earnings per share, diluted | −0.70 | −0.51 | −0.64 | −0.85 |
| Metric | 18/08/2026 | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
|---|---|---|---|---|---|---|
| Cash and equivalents | — | 27M | 36M | 78M | 32M | 82M |
| Receivables | — | — | 0 | 15M | — | — |
| Current assets | — | 97M | 172M | 125M | — | — |
| Property, plant and equipment | — | 2M | 3M | 3M | 4M | — |
| Total assets | — | 154M | 231M | 183M | — | — |
| Current liabilities | — | 95M | 101M | 14M | — | — |
| Total liabilities | — | 109M | 119M | 22M | — | — |
| Equity | — | 45M | 112M | 161M | 169M | 232M |
| Metric | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 |
|---|---|---|---|---|
| Operating cash flow | −69M | 66M | −60M | −74M |
| Share-based compensation | 4M | 5M | 4M | 3M |
| Capital expenditure | 900,000 | 576,000 | 801,000 | 1M |
| Investing cash flow | 64M | −105M | 66M | 24M |
| Financing cash flow | −1M | −1M | 43M | −1M |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator